Table 1.

Main characteristics of the study population.

Study Population (N = 71)	Values
Age (years)	63.8 ± 8.4
Male (%)	45.1
CT evaluation (%)	78.9
MR evaluation (%)	21.1
FOLFIRINOX (%)	45.1
Gemcitabine-Abraxane (%)	32.4
Other CRT protocol (%)	22.5
Dudoenocephalopancreatectomy (%)	78.9